戻る Agenda
Key Initiatives in Europe to Walk the Talk in Patient-Focused Medicines Development - An interactive update and Discussion with Different Stakeholders
Session Chair(s)
Lode Dewulf
Patient and Medical Affairs Consultant
Corvalus, Belgium
Health stakeholders agree on the importance of improving patient engagement (PE) across all phases of medicines development. What can we learn from the experience and perspectives of different stakeholders? How can we use these insights to address challenges and barriers and forge a more collaborative, connected PE ecosystem? What tools are available or in co-creation and how can we measure the impact of our PE efforts? Join us for a dynamic session that will explore these themes, and be an active participant by selecting priority topics to be addressed by PE leaders from diverse stakeholder groups.
Speaker(s)
Panel Discussion
Mathieu Boudes, PhD
Montsouris Consilium, France
Patient Engagement Director
Panel Discussion
Neil Bertelsen, MBA, MSc
Neil Bertelsen Consulting, Germany
Patient Engagement Specialist
Panel Discussion
Soren E Skovlund
Aalborg University, Denmark
Senior Reaearcher, lead, PRO
Panel Discussion
Nicholas Brooke, MBA
PFMD, Belgium
Executive Director, Patient Focused Medicines Development (PFMD)